Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
07/2006
07/13/2006WO2004065367A8 Viral polymerase inhibitors
07/13/2006WO2004010842A3 Lipophilic electrophoretic probes
07/13/2006US20060155122 Thiazol-(bi)cycloalkyl-carboxanilides
07/13/2006US20060154967 e.g. [2-methyl-5-trifluoromethyl-2H-1,2,3-triazole-4-carboxylic acid methyl ester; fungicide; against the phytopathogenic fungi: Fungi imperfecti (Botrytis, Pyricularia, Helminthosporium), Basidiomycetes (Rhizoctonia, Hemileia), Ascomycetes classes (Venturia, Erysiphe), Oomycetes classes (Phytophthora)
07/13/2006US20060154964 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
07/13/2006US20060154961 Thiadiazole compounds and methods of use
07/13/2006US20060154917 Substituted (heterocycloalkyl)methyl azole derivatives as c5a receptor modulators
07/13/2006US20060154913 Drugs for treatment of respiratory syncytial virus and salt formation
07/13/2006US20060154899 Oxazolidin-2-one and thiazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of glaucoma
07/13/2006CA2596393A1 4-(benzyl)-piperazine-1-carboxylic acid phenylamide derivatives and related compounds as modulators of fatty acid amide hydrolase for the treatment of anxiety, pain and other conditions
07/13/2006CA2594418A1 N-(heteroaryl)-1h-indole-2-carb0xamide derivatives and their use as vanilloid trpv1 receptor ligands
07/13/2006CA2594404A1 Non-anilinic derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators
07/13/2006CA2594347A1 Tricyclic d-opioid modulators
07/13/2006CA2593463A1 [4-(heteroaryl) piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
07/13/2006CA2593044A1 Substituted oxindole derivatives, medicaments containing said derivatives and use thereof
07/13/2006CA2592771A1 Derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators
07/13/2006CA2587195A1 Cycloalkyl keto piperidine tachykinin receptor antagonists
07/12/2006EP1679313A2 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
07/12/2006EP1679310A1 Phenylene derivative having tetrazole ring or thiazolidinedione ring
07/12/2006EP1679074A1 Therapeutic agent for keratoconjunctive disorder
07/12/2006EP1679073A1 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(imino-heterocyclyl)-phenyl-amide derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses
07/12/2006EP1678173A2 4-heterobicyclylamino-substituted quinazolines and analogues thereof as capsaicin-antagonists
07/12/2006EP1678171A1 Pyrimidin-4-yl-3,4-thione compounds and their use in therapy
07/12/2006EP1678170A1 Use of a compound of formula (i) as an inhibitor of aromatase for therapeutic purposes and compounds of formula (1) thereas
07/12/2006EP1678169A1 4-(pyrazol-3-ylamino)pyrimidine derivatives for use in the treatment of cancer
07/12/2006EP1678157A2 Heterocyclic compounds and methods of making and using thereof
07/12/2006EP1678153A1 Thiozolidinones, production and use thereof as medicaments
07/12/2006EP1678149A2 4-amino(aza)quinoline derivatives as capsaicin receptor agonists
07/12/2006EP1678147A1 Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
07/12/2006EP1678137A1 Compositions and methods for viral inhibition
07/12/2006EP1677782A2 Inhibitors of cathepsin s
07/12/2006EP1103547B1 Formazan metal complex
07/12/2006CN1802376A Cgrp受体拮抗剂 Cgrp receptor antagonists
07/12/2006CN1802372A 7-[(1,3-thiazol-2-yl)thio]-coumarin derivatives and their use as leukotriene biosynthesis inhibitors
07/12/2006CN1802371A Aztreonam beta-polymorph with very low residual solvent content
07/12/2006CN1802368A Heteroaryl-substituted imdazole derivatives as glutamate receptor antagonists
07/12/2006CN1802366A C-glycoside derivatives and salts thereof
07/12/2006CN1802187A Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
07/12/2006CN1800180A Ampiroxicam refining method
07/12/2006CN1263754C Monomer for use in preparation of a polymer to be used in optical devices
07/12/2006CN1263751C Novel compounds
07/12/2006CN1263748C A process for the preparation of bis-benzazolyl compounds
07/12/2006CN1263746C Pyridazinone derivatives
07/11/2006US7074934 Serine protease inhibitors
07/11/2006US7074819 Benzopyran or thiobenzopyran derivatives
07/11/2006US7074811 for use in the treatment and/or prophylaxis of diabetes mellitus
07/11/2006US7074810 Triazolone and triazolethione derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme
07/11/2006US7074809 Exhibiting an activity at metabotropic glutamate receptors (mGluRs), especially at the mGluR5 receptor
07/11/2006US7074808 4-(Phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestional disorders
07/11/2006US7074801 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof
07/11/2006US7074800 Quinazoline derivatives as angiogenesis inhibitors
07/11/2006US7074799 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity
07/11/2006US7074794 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor
07/11/2006US7074789 Kinase inhibitors
07/11/2006US7074788 Antidiabetic agents; liver disorders; cardiovascular disorders; dietetics
07/11/2006US7074787 Controlling, prevention plant infections; fungicides, nematocides, insecticides
07/11/2006US7074784 Medicaments against viral diseases
07/11/2006US7074532 Linked dihydrazone-based charge transport compounds
07/11/2006CA2395114C 3-thiazol-4-yl-pyprolidine derivatives as amp-specific phosphodiesterase inhibitors
07/11/2006CA2285548C Nicotinamide derivatives
07/11/2006CA2260999C Heterocyclic compounds, their production and use in tyrosine kinase inhibition
07/11/2006CA2244870C N,n-disubstituted amic acid derivatives
07/11/2006CA2217137C Process for preparation of 3-piperazinylbenzisothiazoles
07/11/2006CA2206532C Novel amidinonaphthyl derivative or salt thereof
07/11/2006CA2163244C Quinoline derivatives as leukotriene antagonists
07/11/2006CA2158609C 5 .alpha.-reductase inhibitors
07/11/2006CA2125824C Heteroaryl coumarins as inhibitors of leukotriene biosynthesis
07/06/2006WO2006070806A1 Novel benzimidazole compound and medicinal composition containing the compound
07/06/2006WO2006070198A1 Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases
07/06/2006WO2006070192A1 Thiazole and isothiazole derivatives that modulate the acivity of cdk, gsk and aurora kynases
07/06/2006WO2006070001A1 Substituted indole ligands for the orl-1 receptor
07/06/2006WO2006069946A1 Substituted pyrrolidinones having an antithrombotic effect, the production thereof and their use as medicaments
07/06/2006WO2006069788A1 Organic compounds
07/06/2006WO2006069776A1 5-ht7 receptor antagonists
07/06/2006WO2006069740A1 2, 5 and 2, 6-disubstituted benzazole analogues useful as protein kinase inhibitors
07/06/2006WO2005116002A3 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/06/2006US20060149066 Imidazole derivatives
07/06/2006US20060149059 Phthalazinone derivatives
07/06/2006US20060149054 Method for manufacture of ceftiofur
07/06/2006US20060148865 Preparation of chemical compounds
07/06/2006US20060148862 Novel compounds that modulate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
07/06/2006US20060148858 1, 2-Azole derivatives with hypoglycemic and hypolipidemic activity
07/06/2006US20060148856 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
07/06/2006US20060148855 Carboxamide derivatives
07/06/2006US20060148850 4-{'3-(Sulfonylamino) phenyl!'1-(cyclymethyl) piperidin-4-ylidene! methyl}benazmide derivativess as delta opioid receptor ligands for the treatment of pain, anxiety and functional gastrointestinal disorder
07/06/2006US20060148834 Novel coumarin-amide derivatives and its preparation, said drug composition and its use
07/06/2006US20060148822 5-Phenylthiazole derivatives and their use as p13 kinase inhibitors
07/06/2006US20060148817 Pyrazole compounds
07/06/2006US20060148814 4-(2-Pyridyl)-1-amino(thio)carbonylpiperazine derivatives are antagonists of the mGluR5 receptor
07/06/2006US20060148793 beta-aryl-alpha-oxysubstituted alkylcarboxylic acids, usch as Ethyl (E/Z)-3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropenoate, used as antilipemic or hypoglycemic agents
07/06/2006US20060148791 Glutamate receptor antagonists
07/06/2006US20060148779 Calcitonin Gene-Related Peptide (CGRP) antagonists for migraine and cluster headaches; 5'-acylamino-spiro[imidazolidine-4,2'-indane]-2,5-dione derivatives
07/06/2006US20060148649 Substituted n-aryl nitrogen heterocycles
07/06/2006DE112004001572T5 Verfahren Method
07/06/2006DE102004062544A1 Neue substituierte Pyrrolidinone, deren Herstellung und deren Verewendung als Arzneimittel New substituted pyrrolidinones, their preparation and their Verewendung as medicaments
07/06/2006DE102004061750A1 Heteroaryl-substituierte Pyrazoline Heteroaryl substituted pyrazolines
07/06/2006CA2592509A1 Benzazole analogues and uses thereof
07/06/2006CA2592131A1 Substituted pyrrolidinones having an antithrombotic effect, the production thereof and their use as medicaments
07/06/2006CA2590666A1 5-ht7 receptor antagonists
07/06/2006CA2587348A1 Organic compounds